Second edition

03.qxd 3/10/08 9:32 AM Page 109
Mahoney CA, Arieff AI. Uremic encephalopathies: clinical,
biochemical, and experimental features. Am J Kidney Dis 1982;
2:324–36.
Malamud N, Hirano A, Kurland LT. Pathoanatomic changes in
amyotrophic lateral sclerosis on Guam. Neurology 1961;
5:401–14.
Malur C, Pasol E, Francis A. ECT for prolonged catatonia. J ECT
2001; 17:55–9.
Manford MR, Fish DR, Shorvon SD. Startle provoked epileptic
seizures: features in 19 patients. J Neurol Neurosurg Psychiatry
1996; 61: 151–6.
Mann SC, Caroff SN, Bleir HR et al. Lethal catatonia. Am J
Psychiatry 1986; 143:1374–81.
Manyam BV, Walters AS, Naria KR. Bilateral striatopallidodentate
calcinosis: clinical characteristics of patients seen in a
registry. Mov Disord 2001; 16:258–64.
Maraganore DM, Folger WN, Swanson JW et al. Movement
disorders as sequelae of central pontine myelinolysis: report of
three cases. Mov Disord 1992; 7:142–8.
Marder K, Ming-Xin T, Cote L et al. The frequency and associated
risk factors for dementia in patients with Parkinson’s disease.
Arch Neurol 1995; 52:695–701.
de Mari M, De Blasi R, Lamberti P et al. Unilateral pallidal lesion
after acute disulfiram intoxication: a clinical and magnetic
resonance imaging study. Mov Disorders 1993; 8:247–9.
Marsden CD, Harrison MJG. Idiopathic torsion dystonia (dystonia
musculorum deformans): a review of forty-two patients. Brain
1974; 97:793–810.
Marti-Masso JF, Poza JJ. Cinnarizine-induced parkinsonism: ten
years later. Mov Disord 1998; 13:453–6.
Martin JP, Alcock NS. Hemichorea associated with a lesion of the
corpus luysii. Brain 1934; 57:504–16.
Martin WE, Loewenson RB, Resch JA et al. Parkinson’s disease:
clinical analysis of 100 patients. Neurology 1973; 23:
783–90.
Martinez-Cage JM, Marsden CD. Hemi-dystonia secondary to
localized basal ganglia tumors. J Neurol Neurosurg Psychiatry
1984; 47:704–9.
Martland HS. Punch drunk. J Am Med Assoc 1928; 91:1103–7.
Mathews WB. Familial calcification of the basal ganglia with
response to parathormone. J Neurol Neurosurg Psychiatry
1957; 20:172–7.
Matsunaga K, Uozumi T, Qingrui L et al. Amantadine-induced
cortical myoclonus. Neurology 2001; 56:279–80.
Matsuo H, Takashima H, Kishikawa M et al. Pure akinesia: an
atyical manifestation of progressive supranuclear palsy.
J Neurol Neurosurg Psychiatry 1991; 54:397–400.
Matsuo H, Kamakura K, Saito M et al. Familial paroxysmal
dystonic choreoathetosis. Clinical findings in a large Japanese
family and genetic linkage to chromosome 2q. Arch Neurol
1999; 56:721–6.
Mayeux R, Denaro J, Hemenegildo N et al. A population-based
investigation of Parkinson’s disease with and without
dementia: relationship to age and gender. Arch Neurol 1992;
49:492–7.
McKee D, Talbot P. Chorea as a presenting feature of variant
Creutzfeldt–Jakob disease. Mov Disord 2003; 18:837–8.
References 109
McLean DR, Jacobs H, Mielke BW. Methanol poisoning: a clinical
and pathological study. Ann Neurol 1980; 8:161–7.
McNeill A. Chorea induced by low-dose tranzodone. Eur Neurol
2006; 55:101–12.
Medlock MD, Cruse RS, Winek SJ et al. A 10-year experience with
postpartum chorea. Ann Neurol 1993; 34:820–6.
Melamed E. Early-morning dystonia, a late effect of long-term
levodopa therapy in Parkinson’s disease. Arch Neurol 1979;
36:308–10.
Melamed E, Korn-Lubetzk I, Reches A et al. Hemiballismus:
detection of focal hemorrhage in subthalamic nucleus by CT
scan. Ann Neurol 1978; 4:582.
Mendhekar DN, Duggal HS. Isolated oculogyric crisis on clozapine
discontinuation. J Neuropsychiatry Clin Neurosci 2006;
18:424–5.
Menza MA, Cocchiola J, Golbe LI. Psychiatric symptoms in
progressive supranuclear palsy. Psychosomatics 1995;
36:550–4.
Mercadante S. Pathophysiology and treatment of opioid-related
myoclonus in cancer patients. Pain 1998; 74:5–9.
Meseguer E, Taboada R, Sanchez V et al. Life-threatening
parkinsonism induced by Kava-Kava. Mov Disord 2002;
17:195–6.
Meyer T, Ludolph AC, Munch C. Ifosfamide encephalopathy
presenting with asterixis. J Neuol Sci 2002; 15:85–8.
Meythaler JM, Roper JF, Brunner RC. Cyproheptadine for
intrathecal baclofen withdrawal. Arch Phys Med Rehabil 2003;
84:638–42.
Miller DD, Sharafuddin MJA, Kathol RG. A case of clozapineinduced
neuroleptic malignant syndrome. J Clin Psychiatry
1991; 52:99–101.
Misra PC, Hay GG. Encephalitis presenting as acute schizophrenia.
Br Med J 1971; 1:532–3.
Mitchell E, Mathews KL. Gilles de la Tourette’s disorder associated
with pemoline. Am J Psychiatry 1980; 137:1618–19.
Miwa H, Harori K, Kondo T et al. Thalamic tremor: case reports
and implications of the tremor-generating mechanism.
Neurology 1996; 46:75–9.
Miyagi Y, Shima F, Ishido K et al. Posteroventral pallidotomy for
midbrain tremor after a pontine hemorrhage. Case report.
J Neurosurg 1999; 91:885–8.
Moersch FP, Kernohan JW. Hemiballismus: a clinicopathologic
study. Arch Neurol Psychiatry 1939; 41:365–72.
Molinuevo JL, Marti MJ, Blesa R et al. Pure akinesia: an unusual
phenotype of Hallervorden–Spatz syndrome. Mov Disord 2003;
18:1351–3.
Mones RJ, Elizan TS, Siegel GJ. Analysis of L-dopa induced
dyskinesias in 51 patients with parkinsonism. J Neurol
Neurosurg Psychiatry 1971; 34:668–73.
Morres CA, Dire DJ. Movement disorders as a manifestation of
nonketotic hyperglycemia. J Emerg Med 1989; 7:359–64.
Morrison JR. Catatonia. Retarded and excited types. Arch Gen
Psychiatry 1973; 28:515–16.
Moshe K, Iulian I, Seth K et al. Clomipramine-induced
tourettism in obsessive-compulsive disorder: clinical and
theoretical implications. Clin Neuropharmacol 1994;
17:338–43.